Get started
Author

Igor Rubinić

Observed names: I. Rubinić, Igor Rubinic, RUBINIĆ, IGOR, Rubinić, Igor
ORCID: 0009-0000-1640-1421
Observed ORCID: 0009-0000-1640-1421
OpenAlex ID: A5017879775
The endocannabinoid system in appetite regulation and treatment of obesity
2024 · Marija Kurtov, Igor Rubinić, et al. · Pharmacology Research & Perspectives · 30
PDF
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
2024 · Igor Rubinić, Marija Kurtov, et al. · Pharmacology Research & Perspectives · 18
PDF
Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy
2023 · Marin Golčić, Luka Simetić, et al. · Cancers · 17
PDF
Artificial intelligence in clinical pharmacology: A case study and scoping review of large language models and bioweapon potential
2023 · Igor Rubinic, Marija Kurtov, et al. · British Journal of Clinical Pharmacology · 16
PDF
Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021
2024 · Igor Rubinić, Vivian H Leung, et al. · Eurosurveillance · 15
A time series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 epidemics: a multicentre cross-national ecological study on behalf of QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics study project
2025 · Marianna Meschiari, José María López Lozano, et al. · Clinical Microbiology and Infection · 10
PDF
Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia
2022 · Vera Vlahović-Palčevski, Igor Rubinić, et al. · Journal of Antimicrobial Chemotherapy · 9
PDF
Institutional and national budget impact of alternative pembrolizumab dosing in non-small cell lung cancer: a real-world pharmacoeconomic analysis
2026 · Igor Rubinić, Robert Likić, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Lyophilised faecal microbiota transplantation capsules for intestinal multidrug-resistant organism decolonisation: protocol for a randomised, double-blind, placebo-controlled trial
2026 · Igor Rubinić, Dora Palčevski, et al. · BMJ Open
PDF
Spotlight commentary: Deprescribing in long‐term care facilities—Towards safer and smarter medication use in older adults
2026 · Nataša Skočibušić, Igor Rubinić, et al. · British Journal of Clinical Pharmacology
Letter to the Editor regarding “Allergological evaluation of hypersensitivity reactions after administration of contrast agents: What the radiologist needs to know” – The role of polyethylene glycol in contrast-induced hypersensitivity
2026 · Igor Rubinić, Dominik Strikić, et al. · European Journal of Radiology
Spotlight Commentary: Deprescribing in long-term care facilities – Towards Safer and Smarter Medication Use in Older Adults
2025 · Nataša Skočibušić, Igor Rubinić, et al.
PDF
1172P Analysis of the microbiome of metastatic melanoma patients with complete response to immunotherapy
2023 · M. Golcic, L. Simetic, et al. · Annals of Oncology
PDF
Kronična Bubrežna Bolest Nakon Akutnog Bubrežnog Oštećenja
2019 · Ita Jelić Pranjić, Lori Srdoč, et al.
Kliničke i laboratorijske karakteristike bolesnika liječenih od akutnog bakterijskog meningitisa u Klinici za infektivne bolesti Kliničkog bolničkog centra Rijeka u razdoblju 2009.-2018.
2019 · Igor Rubinić
Evaluation of Synergistic Antibacterial Efficiency of Tea Tree and Lavender Essential Oils Against Clinical Isolates of Staphylococcus aureus
2018 · Dora Palčevski, Igor Rubinić, et al.
Works count: 18
Citation count: 115
H-index: 7
I10-index: 6
Year
Topic
Type